FDA
label_change
· 2006-10-25
FDA Approved: COMBIVIR — Supplemental Application (ViiV Healthcare Company)
Summary
The FDA approved a supplemental application for COMBIVIR (lamivudine and zidovudine) from ViiV Healthcare Company.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
SUPPL AP for COMBIVIR (LAMIVUDINE AND ZIDOVUDINE)